BioCentury | Jun 17, 2020
Product Development
U.K. approves steroid after master protocol shows survival benefit in COVID-19
...25 patients receiving oxygen would need to be treated with dexamethasone; ventilated patients had an NTT...
...death. Data from Gilead’s 584-patient Phase III SIMPLE study in moderate COVID-19, however, suggests an NTT...
...death. Data from Gilead’s 584-patient Phase III SIMPLE study in moderate COVID-19, however, suggests an NTT...
